| RS2539682486 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2539684506 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539706898 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS2539707454 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS2539708151 |
FKTN
|
Health Risk |
Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539708429 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539709535 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539710078 |
WDR5
|
Health Risk |
Pathogenic |
— |
| RS2539710360 |
FKTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2M, Muscular dystrophy-dystroglycanopathy (congenital without intellectual disability) |
| RS2539710750 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2539711005 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539711496 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539712793 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539712984 |
FKTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539717285 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2539723743 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Congenital myasthenic syndrome 17 |
| RS2539727043 |
LRP4
|
Health Risk |
Likely pathogenic |
— |
| RS2539729986 |
LRP4
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 17, Cenani-Lenz syndactyly syndrome |
| RS2539733866 |
EXT2
|
Health Risk |
Likely pathogenic |
Exostoses, multiple |
| RS2539734963 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS2539739333 |
BRSK2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2539740546 |
BRSK2
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2539741932 |
LRP4
|
Health Risk |
Likely pathogenic |
Cenani-Lenz syndactyly syndrome, Cenani-Lenz syndactyly syndrome |
| RS2539746175 |
LRP4
|
Health Risk |
Likely pathogenic |
Cenani-Lenz syndactyly syndrome, Congenital myasthenic syndrome 17 |
| RS2539749192 |
FKTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1X, Dilated cardiomyopathy 1X |
| RS2539749999 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Sclerosteosis 2 |
| RS2539750587 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Dilated cardiomyopathy 1X |
| RS2539751401 |
ITGA7
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS2539759435 |
LRP4
|
Health Risk |
Pathogenic |
Cenani-Lenz syndactyly syndrome, Sclerosteosis 2 |
| RS2539762676 |
CDK5RAP2
|
Health Risk |
Pathogenic |
Microcephaly 3, primary |
| RS2539766517 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539766693 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539767058 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539767433 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2539767594 |
PCDH15
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2539768291 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539768600 |
BRSK2
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, See cases |
| RS2539768820 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1D, Usher syndrome type 1D |
| RS2539768950 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2539768999 |
PCDH15
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 23, Autosomal recessive nonsyndromic hearing loss 23 |
| RS2539771553 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS2539771559 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539777929 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539777941 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539777975 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539778271 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539779929 |
EXT2
|
Health Risk |
Likely pathogenic |
Exostoses, multiple |
| RS2539780098 |
EXT2
|
Health Risk |
Likely pathogenic |
Exostoses, multiple |
| RS2539783265 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2539783884 |
EXT2
|
Health Risk |
Pathogenic |
Exostoses, multiple |
| RS2539784575 |
HRAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Costello syndrome, Cardiovascular phenotype |
| RS2539792278 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539797147 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2539797407 |
HRAS
|
Health Risk |
Likely pathogenic |
Vascular malformation, Vascular malformation |
| RS2539798184 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2539799070 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2539799194 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539799215 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539799335 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2539799464 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2539801815 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2539802611 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539802789 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2539802827 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539802835 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539809075 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539809141 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539813901 |
GLUD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinism-hyperammonemia syndrome, Hyperinsulinism-hyperammonemia syndrome |
| RS2539816286 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539816328 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539816577 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539820167 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539820308 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539820419 |
GLUD1
|
Health Risk |
Pathogenic |
— |
| RS2539820425 |
GLUD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperinsulinism-hyperammonemia syndrome, Familial hyperinsulinism |
| RS2539820655 |
STXBP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS2539820701 |
STXBP1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539821402 |
LOC340512;ZNF462
|
Health Risk |
Likely pathogenic |
Weiss-Kruszka syndrome, Weiss-Kruszka syndrome |
| RS2539827928 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539834004 |
ZMYND11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2539834154 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539834585 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539834708 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539834747 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2539835039 |
STXBP1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539835265 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS2539848777 |
LRRC56
|
Health Risk |
Pathogenic/Likely pathogenic |
Ciliary dyskinesia, primary |
| RS2539849600 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS2539860779 |
TMEM138
|
Health Risk |
Likely pathogenic |
— |
| RS2539862950 |
PAK1
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with macrocephaly, seizures |
| RS2539869968 |
TMEM138
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 16, Joubert syndrome 16 |
| RS2539874340 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2539890521 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome 2, Joubert syndrome 2 |
| RS2539891609 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2539891669 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome 2, Joubert syndrome 2 |
| RS2539891739 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2539892764 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome 2, Joubert syndrome 2 |
| RS2539892774 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS2539892830 |
TMEM216
|
Health Risk |
Likely pathogenic |
Joubert syndrome 2, Joubert syndrome 2 |
| RS2539892835 |
TMEM216
|
Health Risk |
Pathogenic |
Joubert syndrome 2, Joubert syndrome 2 |